HealthEquity (NASDAQ:HQY) Rating Increased to Buy at Wall Street Zen

HealthEquity (NASDAQ:HQY) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Monday.

A number of other research analysts have also weighed in on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. The Goldman Sachs Group lowered HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price objective on the stock. in a research note on Friday, January 9th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $120.00 price objective on shares of HealthEquity in a report on Friday, December 5th. Citizens Jmp lifted their target price on HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a report on Thursday, December 4th. Finally, Citigroup reiterated an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $119.60.

HealthEquity Trading Down 1.8%

Shares of HQY opened at $85.37 on Monday. HealthEquity has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The business has a 50-day moving average of $96.16 and a 200 day moving average of $94.49. The firm has a market cap of $7.29 billion, a P/E ratio of 39.16, a price-to-earnings-growth ratio of 1.23 and a beta of 0.20. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.90 by $0.11. The business had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The company’s revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, research analysts forecast that HealthEquity will post 2.32 EPS for the current year.

Insider Activity

In other news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares in the company, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares of the company’s stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 13,959 shares of company stock worth $1,344,957. Insiders own 1.50% of the company’s stock.

Institutional Trading of HealthEquity

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Econ Financial Services Corp raised its stake in shares of HealthEquity by 39.9% during the fourth quarter. Econ Financial Services Corp now owns 27,249 shares of the company’s stock worth $2,496,000 after acquiring an additional 7,770 shares in the last quarter. Three Seasons Wealth LLC grew its holdings in shares of HealthEquity by 49.8% during the 4th quarter. Three Seasons Wealth LLC now owns 5,521 shares of the company’s stock valued at $506,000 after purchasing an additional 1,836 shares during the last quarter. Private Advisory Group LLC raised its position in HealthEquity by 6.2% in the 4th quarter. Private Advisory Group LLC now owns 101,382 shares of the company’s stock worth $9,288,000 after purchasing an additional 5,875 shares during the period. Chesley Taft & Associates LLC lifted its stake in HealthEquity by 4.5% in the fourth quarter. Chesley Taft & Associates LLC now owns 26,399 shares of the company’s stock worth $2,418,000 after purchasing an additional 1,139 shares during the last quarter. Finally, Exchange Traded Concepts LLC bought a new stake in HealthEquity in the fourth quarter worth $94,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.